Related Experiment Video
Updated: Jun 7, 2026

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
Published on: March 8, 2022
Common pathogenic pathways in melanoma and Parkinson disease
Coro Paisán-Ruiz1, Henry Houlden
1Molecular Neuroscience Department, UCL Institute of Neurology, University College London, Queen Square, London, UK. cpaisan@gmail.com
None:
There is growing evidence in the scientific literature for shared risk and overlapping disease mechanisms in the development of cancer and Parkinson disease (PD). This association has recently been highlighted with respect to melanoma and PD. Therefore, we review and discuss the literature concerning this unexplained link. A striking overlap is observed in the tyrosine and L-dopa biosynthetic pathways suggesting a common disease mechanism associated with these 2 heterogeneous disorders that warrants further investigation.
Related Concept Videos
Parkinson Disease ll: Pathophysiology
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Parkinson's Disease: Overview
Parkinson Disease l: Introduction
The Intrinsic Apoptotic Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

